Oct 22, 2014
LONDON, UK. 22nd October 2014: A groundbreaking new market report released today by visiongain, an independent business intelligence organisation, indicates that global governmental spending on geospatial intelligence (GEOINT) exploitation solutions and..
Oct 20, 2014
LONDON, UK. 17h October 2014: Visiongain’s analysis indicates that the High Voltage Direct Current (HVDC) transmission market will reach a value of $25.79bn in 2014, with a wide range of projects continuing to be authorised and constructed throughout...
Oct 17, 2014
LONDON, UK. 15th October 2014:Visiongain’s analysis indicates that the marine seismic equipment and acquisition markets will reach a value of $931m and $7,068m respectively in 2014.
Oct 16, 2014
London, UK, 14th October 2014: A new report by visiongain calculates that the molecular diagnostics market will reach $6.13bn in 2014 with revenue showing high overall growth to 2024.
Oct 15, 2014
LONDON, UK. 14th October 2014:Visiongain’s analysis indicates that the total value of the Internet of Things market revenues will reach $756.8 billion by the end of 2014, fuelled by an ever increasing demand from enterprises and consumers.
Oct 14, 2014
LONDON, UK. 10th October 2014: Visiongain’s new report on The Floating Production, Storage and Offloading (FPSO) Market 2014-2024: CapEx on New Build & Converted Vessels indicates that the global FPSO market will see $13.54bn in capital expenditure...
Oct 09, 2014
LONDON, UK. 9th of October 2014: A new report by visiongain predicts that the world market for packaging machinery will reach $37.35bn in 2014.
Oct 08, 2014
LONDON, UK. 8th October 2014: Visiongain’s flagship 584 page report The Homeland Security Market Forecast 2014-2024: Public Safety, Intelligence, Infrastructure, Border, Cybersecurity, Maritime, Aviation, CBRN, Mass Transit therefore provides an...
Oct 02, 2014
LONDON, UK, 1st of October 2014: A new report by visiongain predicts that the world market for all natural food and drink will reach $70.7bn in 2014.
Sep 29, 2014
Between 2009 and 2013, the leading pharmaceutical contract manufacturing organisations based in developed countries struggled for revenue growth. In that period, revenue for the top five developed-market CMOs grew in low single digit figures.